Is tumor volume reduction during radiotherapy prognostic relevant in patients with stage III non-small cell lung cancer?

Durvalumab after Chemoradiotherapy in Stage III Non–Small-Cell Lung Cancer

Scott Antonia, Augusto Villegas, Davey B. Daniel et al. · New England Journal of Medicine · 2017 · 4.5K citations · Full text

Medicine, Oncology, Radiation Oncology +15

Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study

Jeffrey D. Bradley, Rebecca Paulus, Ritsuko Komaki et al. · The Lancet Oncology · 2015 · 2K citations · Full text

Medicine, Oncology, Radiation Oncology +17

Phase III Study of Surgery Versus Definitive Concurrent Chemoradiotherapy Boost in Patients With Resectable Stage IIIA(N2) and Selected IIIB Non–Small-Cell Lung Cancer After Induction Chemotherapy and Concurrent Chemoradiotherapy (ESPATUE)

Wilfried Eberhardt, Christoph Pöttgen, Thomas Gauler et al. · Journal of Clinical Oncology · 2015 · 365 citations

Medicine, Oncology, Surgery +16

Patterns in lung cancer incidence rates and trends by histologic type in the United States, 2004–2009

Keisha A. Houston, S. Jane Henley, Jun Li et al. · Lung Cancer · 2014 · 222 citations · Full text

Medicine, Oncology, Pathology +17

Intra thoracic anatomical changes in lung cancer patients during the course of radiotherapy

Margriet Kwint, S. Conijn, Eva Schaake et al. · Radiotherapy and Oncology · 2014 · 131 citations

Medicine, Oncology, Radiation Oncology +13